A specialized gene editing system designed by scientists at the Lewis Katz School of Medicine at Temple University is paving the way to an eventual cure for patients infected with HIV, the virus that causes AIDS. In a study published online this month in the Nature journal, Scientific Reports, the researchers show that they can both effectively and safely eliminate the virus from the DNA of human cells grown in culture.
According to senior investigator on the new study, Kamel Khalili, PhD, Laura H. Carnell Professor and Chair of the Department of Neuroscience, Director of the Center for Neurovirology, and Director of the Comprehensive NeuroAIDS Center at the Lewis Katz School of Medicine at Temple University (LKSOM), “Antiretroviral drugs are very good at controlling HIV infection. But patients on antiretroviral therapy who stop taking the drugs suffer a rapid rebound in HIV replication.” The presence of numerous copies of HIV weakens the immune system and eventually causes acquired immune deficiency syndrome, or AIDS.
Curing HIV/AIDS – which has claimed the lives of more than 25 million people since it was first discovered in the 1980s – is the ultimate goal in HIV research. But eliminating the virus after it has become integrated into CD4+ T-cells, the cells primarily infected with HIV, has proven difficult. Recent attempts have focused on intentionally reactivating HIV, aiming to stimulate a robust immune response capable of eradicating the virus from infected cells. However, to date, none of these “shock and kill” approaches has been successful.
Dr. Khalili and colleagues decided to try a different approach, specifically targeting HIV-1 proviral DNA (the integrated viral genome) using uniquely tailored gene editing technology. Their system includes a guide RNA that specifically locates HIV-1 DNA in the T-cell genome, and a nuclease enzyme, which cuts the strands of T-cell DNA. Once the nuclease has edited out the HIV-1 DNA sequence, the loose ends of the genome are reunited by the cell’s own DNA repair machinery.
In previous work, Dr. Khalili’s team had demonstrated the ability of their technology to snip out HIV-1 DNA from human cell lines. In their latest study, however, they concentrated on latently and productively infected CD4+ T cells to show not only that the technology eliminates the virus from cells but also that its persistent presence in HIV-1-eradicated cells actually protects them against reinfection. More importantly, they carried their work over to ex vivo experiments, in which T-cells from patients infected with HIV were grown in cell culture, showing that treatment with the gene editing system can suppress viral replication and dramatically reduce viral load in patient cells.
In another major component of the study, Dr. Khalili’s team addressed questions about off-target effects and toxicity. Using an approach known as ultra-deep whole-genome sequencing, which is considered the gold standard for genomic assessment, the researchers analyzed the genomes of HIV-1-eradicated cells for mutations in genes outside the region targeted by the guide RNA. Their analyses ruled out off-target effects on genes, including potential collateral effects on cellular gene expression. Studies of cell viability and proliferation showed that HIV-1-eradicated cells were growing and functioning normally.
“The findings are important on multiple levels,” Dr. Khalili said. “They demonstrate the effectiveness of our gene editing system in eliminating HIV from the DNA of CD4 T-cells and, by introducing mutations into the viral genome, permanently inactivating its replication. Further, they show that the system can protect cells from reinfection and that the technology is safe for the cells, with no toxic effects.”
“These experiments had not been performed previously to this extent,” he added. “But the questions they address are critical, and the results allow us to move ahead with this technology.”
The Latest on: HIV/AIDS
via Google News
The Latest on: HIV/AIDS
- DOH-Eastern Visayas urges pregnant women to get HIV-AIDS teston May 17, 2021 at 3:23 am
The Department of Health (DOH) in Eastern Visayas has encouraged pregnant mothers to have themselves tested for HIV-AIDS (human immunodeficiency virus-acquired deficiency ...
- World AIDS Vaccine Day Quotes And Wishes To Share In Support Of Health Workerson May 17, 2021 at 2:03 am
World AIDS Vaccine Day quotes to share in support of healthcare works, volunteers, scientists and others who are working tirelessly to eradicate the disease ...
- World AIDS Vaccine Day 2021 Theme, Date, Significance And Historyon May 17, 2021 at 2:01 am
What is the date, significance and history of this day? Here is more information about it, read on to know more.
- To end AIDS in the Caribbean, we must end inequalitieson May 17, 2021 at 1:30 am
By Winnie Byanyima UNAIDS Executive Director After seeing an HIV positive colleague harassed in the workplace, a man secretly decides not to get tested. A transgender woman refuses to return to ...
- SPECIAL COVERAGE: ‘AIDS Walk New York: Live At Home’ On CBSN New Yorkon May 16, 2021 at 3:55 pm
Live at Home” from Central Park streamed on CBSN New York on Sunday. The broadcast reached participants across the country and right here in New York City. READ MORE: AIDS Walk: Despite Changes ...
- 4,513 HIV/Aids cases in Davao since ‘93on May 16, 2021 at 7:40 am
Davao Region has recorded a total of 4,513 cases of the still-incurable human immunodeficiency virus/acquired immunodeficiency ...
- UNAIDS urges PH to ensure continuous provision of HIV/AIDS serviceson May 15, 2021 at 5:24 pm
The Philippine government should ensure continuity of HIV/AIDS care services even if it is still grappling with the coronavirus disease (COVID-19) pandemic, the Joint United Nations Programme on ...
- HIV survivors’ stories show the loss, resilience and activism of the early years of AIDS pandemicon May 13, 2021 at 8:28 am
The HIV In My Day project preserves the early history of the HIV/AIDS pandemic through the personal stories of long-term survivors and caregivers.
- AIDS Walk: Those Living With HIV Say Advances In Treatment Have Been Incredible, As Has The Support Systemon May 12, 2021 at 2:50 pm
As we countdown to AIDS Walk this weekend, CBS2 wants to share the stories of two New Yorkers who have been living with HIV for decades. One is a loving mother and the other a Broadway star.
- HIV patients are more likely to die from COVID-19 infectionon May 11, 2021 at 10:31 pm
Over the past year, studies have revealed that certain pre-existing conditions, such as cancer, diabetes and high blood pressure, can increase a person's risk of dying from COVID-19.
via Bing News